IP Library Granted Patent US 8,871,819
Granted Patent B2
US 8,871,819 · App. 13/104,383 · Granted Oct 28, 2014

Glycerol ester active agent delivery systems and methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,871,819
App. No.
13/104,383
Granted
Oct 28, 2014
Kind
B2
Abstract

Embodiments of the invention include glycerol esters and use of the same for active agent delivery systems and methods. In an embodiment, the invention includes an active agent eluting device including a glycerol ester, an active agent dispersed within the glycerol ester, the active agent eluting device configured to elute the active agent from the glycerol ester in response to degradation of the glycerol ester. In an embodiment, the invention includes a composition including a glycerol ester; an active agent dispersed within the glycerol ester; the active agent eluting device configured to elute the active agent from the glycerol ester in response to degradation of the glycerol ester. Other embodiments are also included herein.

Claims (21)

1. A composition comprising:

a glycerol ester polymer comprising at least one polymer selected from the group consisting of tetraglycerol hexyloctanoate, tetraglycerol hexylhexanoate, hexaglycerol octyloctanoate, decaglycerol dodecylhexanoate, tetraglycerol octylhexanoate, decaglycerol dodecyldodecanoate, and decaglycerol dodecyldecanoate;

an active agent dispersed within the glycerol ester polymer;

wherein the composition is configured to have the active agent eluted from the glycerol ester polymer under physiologic conditions.

2. The composition of claim 1 , the composition configured to elute the active agent in response to degradation of the glycerol ester polymer.

3. The composition of claim 2 , wherein degradation of the glycerol ester polymer takes place in vivo.

4. The composition of claim 1 , wherein the glycerol ester polymer has a molecular weight of greater than or equal to 5,000.

5. The composition of claim 1 , wherein the glycerol ester polymer has a melting temperature (Tm) of greater than about 25 degrees Celsius and less than about 37 degrees Celsius.

6. The composition of claim 1 , wherein the glycerol ester polymer comprises an ester group including a carbon chain comprising greater than or equal to 6 carbon atoms.

7. The composition of claim 1 , wherein the glycerol ester polymer comprises an ester group comprising a pendant active agent or proagent as part of the ester group.

8. The composition of claim 1 , wherein the glycerol ester polymer comprises an ester group comprising a covalently bound anti-inflammatory agent.

9. The composition of claim 1 , wherein the glycerol ester glycerol comprises an ester group comprising a salicylate.

10. The composition of claim 1 , wherein the glycerol ester polymer is covalently bonded to a surface of a substrate through a linking group.

11. The composition of claim 10 , wherein the linking group comprises a silane compound.

12. The composition of claim 1 , wherein the glycerol ester polymer is covalently bonded to a surface of a substrate through a photoreactive group.

13. The composition of claim 1 , wherein the glycerol ester polymer is cross-linked with a cross-linking agent.

14. The composition of claim 1 , further comprising a biocompatible polymer dispersed within the glycerol ester polymer.

15. The composition of claim 1 , further comprising a hydrophobic polymer, wherein the glycerol ester polymer serves as a solvent to the hydrophobic polymer.

16. The composition of claim 1 , further comprising microparticles disposed within the glycerol ester polymer.

17. The composition of claim 1 , wherein the backbone of the glycerol ester polymer is fully esterified and the active agent is hydrophobic.

18. The composition of claim 1 , wherein the glycerol ester polymer has a viscosity of between 1,000 and 30,000 cP (centipoise) at 37 degrees Celsius.

Assignments (5)
SECURITY INTEREST Recorded Jan 21, 2026
From: SURMODICS COATINGS, LLC
To: BANK OF MONTREAL, AS COLLATERAL AGENT
Reel/Frame 074461/0162 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 8, 2025
From: SURMODICS, INC.
To: SURMODICS COATINGS, LLC
Reel/Frame 073928/0178 →
RELEASE OF SECURITY INTEREST Recorded Nov 24, 2025
From: MIDCAP FUNDING IV TRUST
To: SURMODICS, INC.; SURMODICS SHARED SERVICES, LLC; SURMODICS HOLDINGS, LLC; SURMODICS COATINGS, LLC; SURMODICS MD, LLC; SURMODICS COATINGS MFG, LLC; SURMODICS IVD, INC.; SURMODICS MD OPERATIONS, LLC; NORMEDIX, INC.
Reel/Frame 073690/0186 →
SECURITY INTEREST Recorded Aug 23, 2024
From: SURMODICS, INC.; SURMODICS SHARED SERVICES, LLC; SURMODICS HOLDINGS, LLC; SURMODICS COATINGS, LLC; SURMODICS MD, LLC; SURMODICS COATINGS MFG, LLC; SURMODICS IVD, INC.; SURMODICS MD OPERATIONS, LLC; NORMEDIX, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 068762/0423 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 8, 2011
From: MEYERING, EMILY R. R.; CHUDZIK, STEPHEN J. (DECEASED); REED, PAMELA IS A LEGAL REPRESENTATIVE OF STEPHEN J. CHUDZIK
To: SURMODICS, INC.
Reel/Frame 026567/0267 →